Back to top
more

MiMedx Group (MDXG)

(Delayed Data from NSDQ)

$6.26 USD

6.26
311,774

-0.01 (-0.16%)

Updated Aug 16, 2024 04:00 PM ET

After-Market: $6.26 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (70 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for MiMedx Group, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 82 66 87 96 69
Receivables 54 44 41 45 32
Notes Receivable 0 0 0 0 0
Inventories 21 13 11 10 9
Other Current Assets 7 11 9 9 13
Total Current Assets 164 134 149 161 123
Net Property & Equipment 7 8 9 11 12
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 41 0 0 0 0
Intangibles 25 26 25 26 28
Deposits & Other Assets 0 0 0 0 0
Total Assets 239 171 188 202 167
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 9 9 7 9 9
Current Portion Long-Term Debt 0 0 0 0 4
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 32 33 33 49 53
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 5 2 2 1 1
Total Current Liabilities 46 44 42 59 67
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 48 49 48 48 62
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2 5 5 4 4
Minority Interest (Liabilities) 0 92 92 92 0
Total Liabilities 96 189 188 202 133
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 276 174 166 159 147
Retained Earnings -134 -192 -162 -151 -102
Other Equity 0 0 0 0 0
Treasury Stock 0 0 4 7 11
Total Shareholder's Equity 143 -18 0 0 34
Total Liabilities & Shareholder's Equity 239 171 188 202 167
Total Common Equity 143 -18 0 0 34
Shares Outstanding 146.20 113.60 112.10 111.00 110.70
Book Value Per Share 0.98 -0.16 0.00 0.00 0.31

Fiscal Year End for MiMedx Group, Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 69 48 82 81 69
Receivables 53 57 54 49 49
Notes Receivable 0 0 0 0 0
Inventories 25 24 21 19 17
Other Current Assets 7 9 7 5 7
Total Current Assets 154 139 164 155 141
Net Property & Equipment 7 7 7 7 7
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 33 39 41 0 0
Intangibles 31 32 25 25 25
Deposits & Other Assets 1 1 0 0 0
Total Assets 230 222 239 189 176
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable 0 0 0 0 0
Accounts Payable 8 10 9 9 8
Current Portion Long-Term Debt 1 1 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 27 27 32 33 34
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 4 4 5 2 2
Total Current Liabilities 40 42 46 44 44
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 18 18 48 49 49
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 4 2 3 3
Minority Interest (Liabilities) 0 0 0 92 92
Total Liabilities 62 66 96 188 189
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 275 280 276 188 183
Retained Earnings -107 -124 -134 -187 -196
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 168 156 143 1 -13
Total Liabilities & Shareholder's Equity 230 222 239 189 176
Total Common Equity 168 156 143 1 -13
Shares Outstanding 146.80 147.60 146.20 116.30 116.10
Book Value Per Share 1.14 1.06 0.98 0.01 -0.11